Previous 10 | Next 10 |
Cue Health Taps Cardinal Health to Distribute its Pioneering Molecular COVID-19 Tests Cue's highly accurate COVID-19 molecular tests will now be available through the expansive Cardinal Health distribution network with reach to hospitals, pharmacies, and non-clinical consumer ma...
Cardinal Health continues its track record of strong revenue growth. Growth in the generics program should add value, and management plans on robust capital returns this year. I also highlight the balance sheet, dividend, valuation, and other points worth considering. For fu...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Members of Sackler family, which own Purdue Pharma, are thinking whether to add $1B to the company's efforts for an opioid settlement bid, Bloomberg News reported citing people familiar with the matter. The move would take the family’s contribution to ~$5.33B to get a fe...
Cardinal Health named one of America's Best Large Employers 2022 by Forbes magazine PR Newswire DUBLIN, Ohio , Feb. 10, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) has been recognized by Forbes as one of America's Best Large Employers 2022 , a list ...
Cardinal Health partners with Kinaxis to optimize digital supply chain planning PR Newswire DUBLIN, Ohio , Feb. 9, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced it will leverage the Kinaxis ® RapidResponse ® platform to increa...
My annual RoR for 2021 is close to 45%. This is better than every national index in Scandinavia, it's more than 2X the DAX, it's significantly above the NASDAQ/others. A few crucial factors allowed this portfolio-wide outperformance, and I will argue that most of you can adopt some of...
Cardinal Health Predicts 2022 to be Turning Point for Biosimilars in the U.S. New report includes research findings on insulin biosimilars use among retail pharmacists and physicians PR Newswire DUBLIN, Ohio , Feb. 7, 2022 /PRNewswire/ -- Today Cardin...
CAH has had a rough go the past few years with the opioid epidemic and coronavirus pandemic impacting their bottom line. Profit margins leave much to be desired and need to improve. Investors can expect a conservative total return CAGR of 14.7% over 5 years. I'm in love with t...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
News, Short Squeeze, Breakout and More Instantly...
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2024 on August 14 PR Newswire DUBLIN, Ohio , July 23, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fisc...
2024-06-28 09:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...